ClinicalTrials.Veeva

Menu

Anal Dilatation for Infants and Children With Constipation

T

Tongji Hospital

Status

Unknown

Conditions

Constipation

Treatments

Drug: Lactulose

Study type

Interventional

Funder types

Other

Identifiers

NCT02255747
Anal Dilatation

Details and patient eligibility

About

This study is to evaluate the effect of anal dilation in infants and children with constipation.

Enrollment

100 estimated patients

Sex

All

Ages

1 month to 14 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Infants and Children With Constipation
  2. Postoperative infants and children with Hirschsprung's disease
  3. Good compliance

Exclusion criteria

  1. Infants and Children With Constipation
  2. Poor compliance

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

100 participants in 2 patient groups

anal dilatation
Active Comparator group
Treatment:
Drug: Lactulose
Oral Lactulose
Active Comparator group
Treatment:
Drug: Lactulose

Trial contacts and locations

1

Loading...

Central trial contact

Zhi Li, MD PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems